Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
programme - European Research Council Executive Agency under grant agreement No 101078370 - AI4SPIN" Equal opportunities: ICN2 is an equal opportunity employer committed to diversity and inclusion of people
-
Offers: An internationally competitive salary, housing allowance, and a high-end family medical plan. An internationally competitive start-up package with long-term research funds and ample laboratory
-
13th Five-Year Plans. During the 14th Five-Year Plan, the high-quality development blueprint of the medicine school has been incorporated into Jiangnan University's “Endeavour Plan." Talent Cultivation
-
ICFO offers a limited number of PhD positions to well-qualified applicants who wish to obtain a doctoral degree in any of the research topics available within our Research Groups . Our PhD-program
-
. This contract has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 101007417 - NEP. Equal opportunities: ICN2 is an equal opportunity employer
-
one or more of the following areas: Large Language Models, Generative Models (AIGC), Natural Language Processing, Computer Vision, or High-Performance Computing. Solid programming skills in Python and
-
Accounting Plan, KPIs, Balance Sheet, P&L, Regional Accounting Standards (CCAA), etc. English: Ability to communicate in English is essential. Advanced Office skills: Excel, Word, PowerPoint. Preferred
-
individual and interdisciplinary, being this a fundamental aspect of the faculty, which is based on a solid research base through its own Research Plan. Evangelization Promoting pastoral care and strengthening
-
. How to apply Candidates should provide a curriculum vitae, a bibliography, and a one-page description of current research activities and future plan. The review of applications will begin on July 1
-
integrating clinical big data and artificial intelligence, the program aims to identify novel therapeutic targets and accelerate the translation of fundamental discoveries into personalized medical solutions